Wealthfront Advisers LLC Exact Sciences Corp Transaction History
Wealthfront Advisers LLC
- $29.7 Billion
- Q2 2024
A detailed history of Wealthfront Advisers LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 5,589 shares of EXAS stock, worth $287,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,589
Previous 7,784
28.2%
Holding current value
$287,721
Previous $537,000
56.05%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EXAS
# of Institutions
656Shares Held
167MCall Options Held
1.96MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA18.2MShares$936 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$849 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$761 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$621 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$423 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.11B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...